|
ICON plc
linear mixed-effects model Linear Mixed Effects Model, supplied by ICON plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/nonlinear+mixed-effect+modeling+software+nonmem+version+7%2E1%2E0/linear+mixed+effects+model/pmc05049657-38-19-25 Average 90 stars, based on 1 article reviews
linear mixed-effects model - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
ICON plc
nonlinear mixed-effect modeling software nonmem version 7.1.0 Nonlinear Mixed Effect Modeling Software Nonmem Version 7.1.0, supplied by ICON plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/nonlinear+mixed-effect+modeling+software+nonmem+version+7%2E1%2E0/nonlinear+mixed+effects+modeling+software+nonmem+version+7+4+4/pmc04335897-163-8-14 Average 90 stars, based on 1 article reviews
nonlinear mixed-effect modeling software nonmem version 7.1.0 - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Journal of Clinical Pharmacology
Article Title: Linear mixed‐effects model of QTc prolongation for olmesartan medoxomil
doi: 10.1002/jcph.572
Figure Lengend Snippet: Stepwise Minimum Objective Function Changes for Linear Mixed‐Effects Model for the Dependent Variables ΔΔQTc, ΔΔQTcF, or ΔΔQTcP
Article Snippet: Linear regression models for olmesartan plasma concentrations and ΔΔQTc were assessed for the 2 olmesartan treatments using a linear
Techniques:
Journal: Journal of Clinical Pharmacology
Article Title: Linear mixed‐effects model of QTc prolongation for olmesartan medoxomil
doi: 10.1002/jcph.572
Figure Lengend Snippet: Parameter Estimates for the Linear Mixed‐Effects Model for the Effect of Olmesartan Plasma Concentrations (OM conc ) and Baseline‐Corrected, Placebo‐Adjusted Heart Rate (ΔΔRR) on ΔΔQTc
Article Snippet: Linear regression models for olmesartan plasma concentrations and ΔΔQTc were assessed for the 2 olmesartan treatments using a linear
Techniques: Clinical Proteomics